Rapid Progression of Polypoidal Choroidal Vasculopathy following Third BNT162b2 mRNA Vaccination
The study aimed to describe a case of rapid progression of polypoidal choroidal vasculopathy (PCV) following the third administration of the Pfizer-BioNTech (BNT162b2) mRNA vaccine. A 79-year-old Japanese man visited our hospital with a 1-week history of blurred vision in the left eye 16 h following the administration of the third BNT162b2 mRNA vaccine. The clinical examinations and imaging tests revealed massive submacular hemorrhage (SMH) and excessive subretinal fluid (SRF), owing to PCV in the left eye. No ocular abnormality was observed in the right eye. His medical history included diabetes and ocular history included cataracts, nonproliferative diabetic retinopathy, glaucoma in both eyes, and irregular retinal pigment epithelium elevation in the left eye. Since he received a single intravitreal injection of aflibercept approximately 2 years ago for the treatment of diabetic macular edema in the left eye, the left eye was stable. We performed an intravitreal injection of bevacizumab and combined phacoemulsification with pars plana vitrectomy with gas, including subretinal injection of tissue plasminogen activator to displace the SMH. Thirteen days after the surgery, the SMH and SRF decreased. Although rare, mRNA COVID-19 vaccine administrations could be associated with PCV deterioration.
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Rapid Progression of Polypoidal Choroidal Vasculopathy following Third BNT162b2 mRNA Vaccination ; volume:13 ; number:2 ; year:2022 ; pages:459-464 ; extent:6
Case reports in ophthalmology ; 13, Heft 2 (2022), 459-464 (gesamt 6)
- Urheber
-
Sasajima, Hirofumi
Zako, Masahiro
Maeda, Rio
Ueta, Yoshiki
- DOI
-
10.1159/000525151
- URN
-
urn:nbn:de:101:1-2022092200582701933102
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:37 MESZ
Datenpartner
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Sasajima, Hirofumi
- Zako, Masahiro
- Maeda, Rio
- Ueta, Yoshiki
Ähnliche Objekte (12)
Miller Fisher syndrome following BNT162b2 mRNA coronavirus 2019 vaccination
Choroidal nevus and polypoidal vasculopathy: case series
Noninvasive multimodal imaging in diagnosing polypoidal choroidal vasculopathy
Clinical implications of pachyvessels in polypoidal choroidal vasculopathy
Polypoidal Choroidal Vasculopathy Associated with Optic Disc Coloboma
Responsiveness of eyes with polypoidal choroidal vasculopathy with choroidal hyperpermeability to intravitreal ranibizumab
Therapeutic effects of ranibizumab in patients with polypoidal choroidal vasculopathy
Intravitreal aflibercept for active polypoidal choroidal vasculopathy without active polyps
Quantitative analysis of choroidal vasculature in polypoidal choroidal vasculopathy using ultra-widefield indocyanine green angiography
Exploring the Ability of Novel Choroidal Biomarkers in Predicting Treatment Outcomes of Polypoidal Choroidal Vasculopathy
Acquired thrombotic thrombocytopenic purpura after first vaccination dose of BNT162b2 mRNA COVID-19 vaccine
Acquired thrombotic thrombocytopenic purpura after first vaccination dose of BNT162b2 mRNA COVID-19 vaccine
Miller Fisher syndrome following BNT162b2 mRNA coronavirus 2019 vaccination
Choroidal nevus and polypoidal vasculopathy: case series
Noninvasive multimodal imaging in diagnosing polypoidal choroidal vasculopathy
Clinical implications of pachyvessels in polypoidal choroidal vasculopathy
Polypoidal Choroidal Vasculopathy Associated with Optic Disc Coloboma
Responsiveness of eyes with polypoidal choroidal vasculopathy with choroidal hyperpermeability to intravitreal ranibizumab
Therapeutic effects of ranibizumab in patients with polypoidal choroidal vasculopathy
Intravitreal aflibercept for active polypoidal choroidal vasculopathy without active polyps
Quantitative analysis of choroidal vasculature in polypoidal choroidal vasculopathy using ultra-widefield indocyanine green angiography
Exploring the Ability of Novel Choroidal Biomarkers in Predicting Treatment Outcomes of Polypoidal Choroidal Vasculopathy
Acquired thrombotic thrombocytopenic purpura after first vaccination dose of BNT162b2 mRNA COVID-19 vaccine
Acquired thrombotic thrombocytopenic purpura after first vaccination dose of BNT162b2 mRNA COVID-19 vaccine
Miller Fisher syndrome following BNT162b2 mRNA coronavirus 2019 vaccination
Choroidal nevus and polypoidal vasculopathy: case series
Noninvasive multimodal imaging in diagnosing polypoidal choroidal vasculopathy
Clinical implications of pachyvessels in polypoidal choroidal vasculopathy
Polypoidal Choroidal Vasculopathy Associated with Optic Disc Coloboma
Responsiveness of eyes with polypoidal choroidal vasculopathy with choroidal hyperpermeability to intravitreal ranibizumab
Therapeutic effects of ranibizumab in patients with polypoidal choroidal vasculopathy
Intravitreal aflibercept for active polypoidal choroidal vasculopathy without active polyps
Quantitative analysis of choroidal vasculature in polypoidal choroidal vasculopathy using ultra-widefield indocyanine green angiography
Exploring the Ability of Novel Choroidal Biomarkers in Predicting Treatment Outcomes of Polypoidal Choroidal Vasculopathy
Acquired thrombotic thrombocytopenic purpura after first vaccination dose of BNT162b2 mRNA COVID-19 vaccine